These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32595610)

  • 21. Rare actinomycetes: a potential storehouse for novel antibiotics.
    Tiwari K; Gupta RK
    Crit Rev Biotechnol; 2012 Jun; 32(2):108-32. PubMed ID: 21619453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Old and new glycopeptide antibiotics: From product to gene and back in the post-genomic era.
    Marcone GL; Binda E; Berini F; Marinelli F
    Biotechnol Adv; 2018; 36(2):534-554. PubMed ID: 29454983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in Antarctic Research for Antimicrobial Discovery: A Comprehensive Narrative Review of Bacteria from Antarctic Environments as Potential Sources of Novel Antibiotic Compounds Against Human Pathogens and Microorganisms of Industrial Importance.
    Núñez-Montero K; Barrientos L
    Antibiotics (Basel); 2018 Oct; 7(4):. PubMed ID: 30347637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and characterization of antimicrobial compounds from Terminalia phanerophlebia Engl. & Diels leaf extracts.
    Madikizela B; Aderogba MA; Finnie JF; Van Staden J
    J Ethnopharmacol; 2014 Oct; 156():228-34. PubMed ID: 25218320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toward a new focus in antibiotic and drug discovery from the Streptomyces arsenal.
    Antoraz S; Santamaría RI; Díaz M; Sanz D; Rodríguez H
    Front Microbiol; 2015; 6():461. PubMed ID: 26029195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multidrug Intrinsic Resistance Factors in Staphylococcus aureus Identified by Profiling Fitness within High-Diversity Transposon Libraries.
    Rajagopal M; Martin MJ; Santiago M; Lee W; Kos VN; Meredith T; Gilmore MS; Walker S
    mBio; 2016 Aug; 7(4):. PubMed ID: 27531908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010004. PubMed ID: 28000919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic Bactericidal Activity Is Countered by Maintaining pH Homeostasis in Mycobacterium smegmatis.
    Bartek IL; Reichlen MJ; Honaker RW; Leistikow RL; Clambey ET; Scobey MS; Hinds AB; Born SE; Covey CR; Schurr MJ; Lenaerts AJ; Voskuil MI
    mSphere; 2016; 1(4):. PubMed ID: 27579369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [From "Løveapotekets kemiske Fabrik" to LEO Pharma A/S].
    Schrøder P
    Theriaca; 2005; (36):27-118. PubMed ID: 17144611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic analysis reveals different mechanisms of fusidic acid resistance in Staphylococcus aureus from Danish atopic dermatitis patients.
    Edslev SM; Clausen ML; Agner T; Stegger M; Andersen PS
    J Antimicrob Chemother; 2018 Apr; 73(4):856-861. PubMed ID: 29253168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small and lethal: searching for new antibacterial compounds with novel modes of action.
    Pathania R; Brown ED
    Biochem Cell Biol; 2008 Apr; 86(2):111-5. PubMed ID: 18443624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Docking into Mycobacterium tuberculosis Thioredoxin Reductase Protein Yields Pyrazolone Lead Molecules for Methicillin-Resistant Staphylococcus aureus.
    Sweeney NL; Lipker L; Hanson AM; Bohl CJ; Engel KE; Kalous KS; Stemper ME; Sem DS; Schwan WR
    Antibiotics (Basel); 2017 Jan; 6(1):. PubMed ID: 28134858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Facilitation of horizontal transfer of antimicrobial resistance by transformation of antibiotic-induced cell-wall-deficient bacteria.
    Woo PC; To AP; Lau SK; Yuen KY
    Med Hypotheses; 2003 Oct; 61(4):503-8. PubMed ID: 13679020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening strategies for discovery of antibacterial natural products.
    Singh SB; Young K; Miesel L
    Expert Rev Anti Infect Ther; 2011 Aug; 9(8):589-613. PubMed ID: 21819327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nutrient stress is a target for new antibiotics.
    Carfrae LA; Brown ED
    Trends Microbiol; 2023 Jun; 31(6):571-585. PubMed ID: 36709096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postgenomic strategies in antibacterial drug discovery.
    Brötz-Oesterhelt H; Sass P
    Future Microbiol; 2010 Oct; 5(10):1553-79. PubMed ID: 21073314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The history of antibiotics].
    Yazdankhah S; Lassen J; Midtvedt T; Solberg CO
    Tidsskr Nor Laegeforen; 2013 Dec; 133(23-24):2502-7. PubMed ID: 24326504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Concept of an Ideal Antibiotic: Implications for Drug Design.
    Gajdács M
    Molecules; 2019 Mar; 24(5):. PubMed ID: 30832456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotics: natural products essential to human health.
    Demain AL
    Med Res Rev; 2009 Nov; 29(6):821-42. PubMed ID: 19291695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.